MaxiVax SA

City:

Geneva

Country:

Switzerland

Published Applications:

Last publication date:

2017-04-06

Patent Grants:

Last grant date:

2018-01-09

Top Inventors for applications by MaxiVax SA

These are the the leading inventors for applications assigned to MaxiVax SA:

Nicolas Mach 3 Collonge-Bellerive, Switzerland

Recent patent applications by MaxiVax SA

MaxiVax SA based in Geneva, CH has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2017-04-06 ✅ Patent 9,861,689 granted on 2018-01-09

US20170095546A1

Human necessities

Vaccination with immuno-isolated cells producing an immunomodulator

#2 | 2017-03-30 ✅ Patent 11,013,790 granted on 2021-05-25

US20170087234A1

Human necessities

Vaccination with immuno-isolated cells producing an immunomodulator

#3 | 2014-11-20 ✅ Patent 9,814,682 granted on 2017-11-14

US20140341982A1

Human necessities

Vaccination with immuno-isolated cells producing an immunomodulator

Also check out Maxivax SA's (Geneva, Switzerland) applicant profile with 3 patent applications submitted.

AssigneeID:

531179 ⎘